BREAST FEEDING;
BREAST MILK;
DRUG COST;
FOLLOW UP;
HEALTH PROGRAM;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION;
MATERNAL WELFARE;
NONHUMAN;
NOTE;
PREGNANCY;
PRIORITY JOURNAL;
RISK ASSESSMENT;
VIRUS TRANSMISSION;
AFRICA;
CHEMOPROPHYLAXIS;
DISEASE TRANSMISSION;
DRUG ADMINISTRATION;
FEMALE;
HEALTH CARE DELIVERY;
HEALTH SERVICE;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INFANT;
NEWBORN;
AFRICA;
ANTI-RETROVIRAL AGENTS;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
BREAST FEEDING;
CHEMOPREVENTION;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HEALTH SERVICES ACCESSIBILITY;
HIV INFECTIONS;
HIV-1;
HUMANS;
INFANT;
INFANT, NEWBORN;
INFECTIOUS DISEASE TRANSMISSION, VERTICAL;
MATERNAL HEALTH SERVICES;
PREGNANCY;
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999; 354:795-802.
World Health Organization (WHO), Geneva: WHO Department of HIV/AIDS, Available at, Accessed 2 October 2009
World Health Organization (WHO). Prevention of mother-to-child transmission (PMTCT): briefing note. Geneva: WHO Department of HIV/AIDS, 2007. Available at: http://www.who.int/hiv/pub/toolkits/ PMTCT%20HIV%20Dept%20brief%20Oct%2007.pdf. Accessed 2 October 2009.
World Health Organization (WHO), Geneva: WHO, Available at, Accessed 2 October 2009
World Health Organization (WHO). Towards universal access: scaling up priority HIV/AIDS interventions in the health sector: progress report 2008. Geneva: WHO, 2008. Available at:http://www.who.int/hiv/pub/towards-universal- access-report-2008.pdf. Accessed 2 October 2009.
Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy
in this issue
Taha TE, Kumwenda J, Cole SR, et al. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy. J Infect Dis 2009; 200:1490-1497 (in this issue).
Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis
Coutsoudis A, Dabis F, Fawzi W, et al. Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis. J Infect Dis 2004; 189:2154-2166
Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach
Tonwe-Gold B, Ekouevi DK, Viho I, et al. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach. PLoS Med 2007; 4:e257.
Comparison of CD4 cell count, viral load, and other markers for the prediction of mortality among HIV-1-infected Kenyan pregnant women
Brown ER, Otieno P, Mbori-Ngacha DA, et al. Comparison of CD4 cell count, viral load, and other markers for the prediction of mortality among HIV-1-infected Kenyan pregnant women. J Infect Dis 2009; 199:1292-1300
Both maternal HAART and daily infant nevirapine (NVP) are effective in reducing HIV-1 transmission during breastfeeding in a randomized trial in Malawi: 28 week results of the Breastfeeding, Antiretroviral and Nutrition (BAN) study [abstract WELBC103]
Available at, Accessed 2 October 2009
Chasela C, Hudgens M, Jamieson D, et al. Both maternal HAART and daily infant nevirapine (NVP) are effective in reducing HIV-1 transmission during breastfeeding in a randomized trial in Malawi: 28 week results of the Breastfeeding, Antiretroviral and Nutrition (BAN) study [abstract WELBC103]. In: 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (Cape Town, South Africa). 2009. Available at: http://www.ias2009. org/. Accessed 2 October 2009.
